Most of the recent BCR studies in B‐CLL cells focused on measuring the protein expression and phosphorylation level of these molecules, namely, Lyn and Syk kinases, which were reported to be constitutively active and upregulated at the protein level 12, 42. The gene discussed is LYN; the disease is B-cell chronic lymphocytic leukemia.